Table 4.

Outcomes after LT for hepatoblastoma

Author	Patients, n	Criteria for LT	RR, %	RFS, %	OS rate, %
Herden et al. [57]	7	PRETEXT III-IV, adjuvant chemotherapy	Median 7.1 years 0	Median 7.1 years 100	Median 7.1 years 100
Okur et al. [91]	10	PRETEXT III-IV, adjuvant chemotherapy		Median 32 (9–69) months 80	Median 32 (9–69) months 80
Hendrickson et al. [92]	6	PRETEXT II-IV, adjuvant chemotherapy	Average 4 (1.4–11.8) years 0	Average 4 (1.4–11.8) years 100	Average 4 (1.4–11.8) years 100
Kulkarni et al. [58]	103	Unresectable tumors, perioperative chemotherapy (99% of cases)			5 years 80.5

LT, liver transplantation; RR, recurrence rate; RFS, recurrence-free survival; OS, overall survival; PRETEXT, Pretreatment Extent of Disease.